NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,802.70+₹41.70 (+2.37%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
Loading market information…
NSE · AMRUTANJAN.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Amrutanjan Health Care Limited’s quoted price sits in the lower half of its reported 52-week range, 34.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Amrutanjan Health Care Limited’s forward annual dividend is ₹5.80 per share, paid semi-annual. The forward yield is 1.17% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Amrutanjan Health Care Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Chennai, India, in 1893, Amrutanjan Health Care Limited, formerly known as Amrutanjan Limited until its renaming in 2007, is a prominent manufacturer, supplier, and vendor of a broad array of wellness products. The company primarily operates across its OTC Products, Beverages, and Others divisions. Its core offerings include ayurvedic pain relief balms, non-alcoholic drinks, and feminine hygiene products. For pain management, Amrutanjan provides a comprehensive range of solutions such as traditional pain balms, various roll-ons, back pain lotions, body pain gels, joint muscle sprays, and diclofenac-based remedies. To address congestion, the company offers cold rubs, cough syrups, nasal inhalers, and Swas Mints. Additionally, its product line features sanitary napkins for women, corn caps, and hand sanitizers. Within its beverage segment, it manufactures juice drinks marketed under the Fruitnik and Fruitnik Electro+ brand names. Amrutanjan also extends its services by operating a pain management center. The company's global presence is marked by product exports to the Middle East, Africa, Southeast Asia, and other international markets.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,802.70+₹41.70 (+2.37%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
₹9,733.00+₹69.00 (+0.71%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
₹646.90-₹34.00 (-4.99%)
Bliss GVS Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 11.74% below the high.
₹113.35-₹5.96 (-5.0%)
Morepen Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 24.78% below the high.
₹1,768.00-₹44.80 (-2.47%)
Evonile Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 31.71% below the high.
₹19.45-₹0.96 (-4.7%)
Syncom Formulations (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 29.1% below the high.
₹883.90-₹39.50 (-4.28%)
Windlas Biotech Limited’s quoted price sits in the lower half of its reported 52-week range, 25.21% below the high.
₹217.00-₹4.94 (-2.23%)
Jagsonpal Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 17.67% below the high.
